CenExel

CenExel CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and ex*****on of phase I-IV clinical trials.

Our attention to detail assures quality results that both sponsors and patients can trust.


The CenExel Centers of Excellence clinical research network includes ACMR, ACT, AMRI, CBH, CIT, CNR, FCR, JBR, RMCR, RCA, iResearch (locations below). Our Centers of Excellence provide unparalleled medical and scientific support in the design and ex*****on of phase I-IV first-in-human cl

inical trials. All of our Centers of Excellence have highly experienced Principal Investigator physicians and research staff serving the following indications; Sleep, Pain Management, Dermatology, Movement Disorders, CNS, Vaccines, Womens Services, and Ethnic-Bridging. Our attention to detail assures quality results that both patients and sponsors can trust, which is evident in the consistency that we achieve and exceed our patient recruitment goals. Our patients' wellness and safety are at the heart of every decision we make. We value our sponsor and CRO relationships and are optimistic about the work we will do together in the future as partners. To speak to our business development team email:
[email protected]. Visit us at cenexelresearch.com for more information. Where are we located? CenExel HQ: Salt Lake City, UT
ACMR, Atlanta, GA
ACT, Anaheim, CA
AMRI, Toms River, NJ
CBH, Gaithersburg, MD
CIT, Anaheim, CA
CNR, Sherman Oaks, CA
FCR, Tampa, FL
IResearch, Atlanta/Savannah
JBR, SLC, UT
RCA, Hollywood, FL
RMCR, Englewood, CO




New publication announcement 📣CenExel is proud to support innovative research advancing potential new treatments for chr...
05/29/2026

New publication announcement 📣

CenExel is proud to support innovative research advancing potential new treatments for chronic neuropathic pain.

A Phase 1/2a trial evaluating KLS-2031, an investigational gene therapy for lumbosacral radiculopathy-induced neuropathic pain, has been published in PAIN Reports.

Congratulations to Dr. Todd Bertoch and the study team on this important publication and contribution to advancing gene therapy research!

Read more at the link in bio!

⭐️ Another reason we do what we do.Huge shoutout to the incredible team at CenExel Decatur for creating such a welcoming...
05/28/2026

⭐️ Another reason we do what we do.

Huge shoutout to the incredible team at CenExel Decatur for creating such a welcoming and supportive experience for our participants. From first-time volunteers to returning patients, compassionate care leaves a lasting impact. 💙

Thank you to Nurses Delight, Victoria, Cheral, Maria, and Coordinator Justina for going above and beyond!

FDA momentum in psychedelic clinical research continues to grow, and CenExel is helping sponsors and CROs navigate the n...
05/27/2026

FDA momentum in psychedelic clinical research continues to grow, and CenExel is helping sponsors and CROs navigate the next generation of clinical development.

Our latest publication highlight showcases the specialized research capabilities, experienced investigators, and scalable patient access supporting psychedelic studies across the CenExel network.

🔗 Click the article link in bio to learn more!

May is Skin Cancer Awareness Month ☀️Early detection can save lives. Knowing the ABCDEs of melanoma, Asymmetry, Border i...
05/25/2026

May is Skin Cancer Awareness Month ☀️

Early detection can save lives. Knowing the ABCDEs of melanoma, Asymmetry, Border irregularity, Color variation, Diameter, and Evolving changes, can help you recognize when it’s time to speak with a healthcare professional.

At CenExel Clinical Research, we’re committed to advancing dermatology research and expanding access to innovative care through clinical trials that help shape the future of medicine.

Learn more about our clinical research studies and mission to improve patient outcomes at the link in bio!

Join CenExel at the 8th Annual Next Generation Ni****ne Delivery USA conference, taking place June 3 to 4 at the Hyatt R...
05/22/2026

Join CenExel at the 8th Annual Next Generation Ni****ne Delivery USA conference, taking place June 3 to 4 at the Hyatt Regency in Miami. As a leading CNS-focused CRO, CenExel is proud to join conversations driving innovation in to***co harm reduction, regulatory science, and next generation ni****ne delivery research!

Meet our team onsite:
• George Hardie, MSc MRSB MICR, Senior Director, To***co Harm Reduction
• Sara Castle, COO, CenExel Decatur
• Heather Beitz, MEd, CEO, CenExel Decatur
• Leslie Gibbs, CCRP, Director of Quality

We look forward to connecting with sponsors, industry leaders, and research partners advancing the future of smoke-free alternatives and clinical development.

****neDeliveryUSA ***coHarmReduction ****ne

05/20/2026

Celebrating the people behind the progress this Clinical Trials Day! 💙

To honor May 20, we asked team members across our sites to share what drives their passion for clinical research, what motivates them each day, and the impact they’ve seen on patients’ lives. From advancing innovation to creating meaningful connections with participants, their answers are a powerful reminder of why this work matters.

Thank you to every team member helping move research forward and making a difference for patients every day.

Hepatitis C often develops silently, with many people experiencing no symptoms until serious liver damage has already oc...
05/19/2026

Hepatitis C often develops silently, with many people experiencing no symptoms until serious liver damage has already occurred. That’s why awareness and early testing matter. 💙

This Hepatitis Testing Day, we’re helping spread awareness about the importance of knowing your status and the role clinical research plays in advancing Hepatitis C treatment and care.

Today’s treatments can cure most cases in as little as 8–12 weeks, and ongoing research continues to improve outcomes for patients everywhere.

Interested in learning more about Hepatitis C clinical research opportunities? Visit the link in our bio!

We’re heading to New Orleans! 🎉Join CenExel at the ADA 86th Scientific Sessions, June 5–8, and stop by Booth 2336 to con...
05/15/2026

We’re heading to New Orleans! 🎉

Join CenExel at the ADA 86th Scientific Sessions, June 5–8, and stop by Booth 2336 to connect with our team.

From metabolic expertise to site operations, we’re excited to meet with sponsors, CROs, and partners driving the future of diabetes research.

📍 Booth 2336
📍 New Orleans, LA

Where in the network is Sy Pretorius? 📍 CenExel DecaturSy Pretorius, MD, CEO, visited CenExel Decatur to connect with He...
05/13/2026

Where in the network is Sy Pretorius? 📍 CenExel Decatur

Sy Pretorius, MD, CEO, visited CenExel Decatur to connect with Heather Beitz, CEO, and Sara Castle, COO, reviewing new site plans and discussing continued growth.

He also spent time with leadership across the network, including Zach Mitchell, CCO; Kristine Meade, CHRO; Erin Monteverdi, Chief of Staff; Sarah Kazmi, MD, COO, Hollywood; Jeff De Leon, MD, PT, COO, Anaheim; and Dalia Botros, MD, COO, supporting multiple California sites.

Excited to see the continued momentum across our network.

👀 Follow along to see where Sy goes next!

Considering an abdominoplasty procedure? Research is helping advance techniques and outcomes in body contouring and surg...
05/11/2026

Considering an abdominoplasty procedure? Research is helping advance techniques and outcomes in body contouring and surgical care.

CenExel is currently enrolling participants for an abdominoplasty clinical trial. Be part of research that supports innovation in surgical treatments and patient outcomes.

Tap the link in our bio to learn if you qualify.

Address

13907 Minuteman Drive #150
Draper, UT
84020

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 9am - 5pm
Sunday 9am - 5pm

Telephone

+18662363935

Alerts

Be the first to know and let us send you an email when CenExel posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share